World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
The origins of the coronavirus and the 2018 NIH lifting of a US ban on virus research that increases transmissibility
06/04/2021
Dr. Fauci, NIH, HHS, lifted the ban on research and manipulation of virus in lab settings in 2018 The role played by the Cambridge Group of scientists who opposed lifting the ban on gain of function research for surveillance purposes. The US public and the public in the world in India, Europe, Asia, Africa and Latin America unaware of what was going on. The devastating effects of the coronavirus in 202 and 2021 and the lack of a vaccine in 2020, lack of a vaccine in sufficient quantities in 2021. The paltry benefits of surveillance compared to the great risks of something going wrong, as pointed out by the Cambridge Group. Why was it ignored in 2018. Who makes decisions for public health in the world. Can the US make decisions for India, the people in Africa, Latin America and Asia. Does even the US public know about it, much less the public in the world at large. What power is given by the US Constitution to US government agencies on matters of public health. How are a few individuals at HHS and NIH accountable to the public in the US and the world at large.
Linked Articles
Opinion | Anthony Fauci and the Wuhan Lab
WSJ 06/03/2021
Ban on gain-of-function studies endsThe Lancet Infectious Diseases 06/04/2021
America, Jobs and Competitiveness- (3) "Getting it right," the legacy of Anthony Liveris at Dow Chemical and Jeffrey Immelt at GE
01/26/2011
Linked Articles
Wall Street Journal 01/26/2011
Dow Chemical's CEO on How to Revive ManufacturingWall Street Journal 02/23/2012
Antonis Samaras and the political opposition to harsh austerity measures in Greece- 2011-2012
07/02/2011
Antonis Samaras of the New Democracy Party opposes tax increases that will further reduce any prospects for economic growth in Greece. As opinion polls show his party passing the socialist party of prime minister Papandreou in popularity in July 2012, any future E.U. agreement for Greece will have to be negotiated with Samaras. The E.U.'s June 2011 plan for Greece faces strong criticism.
Linked Articles
Greek Opposition Slams Tax Rises
Wall Street Journal 07/05/2011
Greece and the euro: The abuses of austerityEconomist 07/02/2011
Reviving American Manufacturing- the views of Anthony Liveris and Andy Grove
07/01/2010
Anthony Liveris is CEO of Dow Chemical and Andy Grove headed Intel Corp.
Linked Articles
Dow Chemical's CEO on How to Revive Manufacturing
Wall Street Journal 02/23/2012
Andy Grove: How America Can Create JobsBusinessWeek 07/01/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us